Cetera Investment Advisers
GCTK icon

Cetera Investment Advisers’s GlucoTrack GCTK Stock Holding History

Cetera Investment Advisers’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17
Closed -$7.46K – 4019
2024
Q4 		$7.46K Buy
17
+9
+113% +$11.4K ﹤0.01% 3731
2024
Q3 		$24.1K Hold
8
– – ﹤0.01% 3645
2024
Q2 		$20.1K Buy
+8
New +$24.1K ﹤0.01% 3650

Other funds holding GCTK

AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cetera Investment Advisers's GCTK Position: Q1 2025 in Review

Cetera Investment Advisers sold out of GlucoTrack (GCTK) in Q1 2025, closing a stake of 17 shares — an estimated $7.46K sold.

Cetera Investment Advisers first reported a position in GCTK in Q2 2024 and held it in 3 quarters. The position peaked at $24.1K in Q3 2024. 4 funds tracked by Wall St. Rank hold GCTK as of Q1 2025.

  • Cetera Investment Advisers reported no remaining GlucoTrack position as of Q1 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 17 GlucoTrack shares in Q1 2025, an estimated $7.46K.
  • Cetera Investment Advisers first reported a position in GlucoTrack in Q2 2024 and held it in 3 quarters.
  • Cetera Investment Advisers's GlucoTrack position peaked at $24.1K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2025.

Based on Cetera Investment Advisers's 13F filing for Q1 2025, filed 6 May 2025.